Elevate Your Bio-Innovation from New Zealand

New Zealand offers a uniquely agile environment for biotech and pharmaceutical growth—combining world-class research, advanced biologics manufacturing, and a culture of collaboration backed by robust IP protection.

Flexible Partnership Models

Select the structure that aligns with your capital plan:

• Leasing – operating leases to suit your needs.

• Project Finance – milestone-based funding that scales with your pipeline.

• Rent-to-Own – build equity in critical facilities while you innovate.

Who We Serve

• Global and domestic pharmaceutical companies scaling clinical or commercial production.

• Public and private research institutes driving next-generation biologics.

• Leading universities advancing translational science and talent development.

Why New Zealand?

• Connected bio-clusters—Auckland’s Grafton Bioscience Precinct, Wellington’s Gracefield Innovation Quarter, and Christchurch’s Te Papa Hauora Health Precinct—deliver dense supplier networks and turnkey infrastructure.

• 15 % R&D Tax Incentive plus Callaghan Innovation project grants cut development costs and accelerate ROI.

• Globally trusted regulator—Medsafe—offers streamlined clinical-trial and GMP approval pathways recognised by major markets.

• Skilled, English-speaking workforce emerging from flagship programmes such as the University of Auckland’s Bioscience Enterprise and Biomedical Science tracks.

• Strategic Asia-Pacific hub with free-trade access to Australia, China, CPTPP partners, and growing Indo-Pacific supply chains.

Let’s Propel Discovery—Together

From green-field builds to capacity expansions and collaborative labs, our team stands ready to make your New Zealand strategy seamless. Connect with us today to see how we can power your next breakthrough.